Articles Tagged With:
-
New FDA Approvals
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA): -
Sertraline effective in pediatric depression
Two recent warnings have led to concerns about the risks of prescribing antidepressants to children. -
Study: Antibiotic use among U.S. children reduced
The overuse of antibiotics in children may be subsiding, according to a study published in the September issue of Pediatrics. -
Federal incentive has increased number of pediatric drug studies
Federal incentive for pharmaceutical companies to study drugs in children has led to improved labeling for several medications. More needs to be done, though, and pharmacists can play a key role in encouraging the process, says one pediatrician. -
News Briefs
Study: Pharmacists intervention can help keep men healthy; Interstitial cystitis study finds limited benefit in two oral drugs; FDA to inform women about menopausal hormone therapy; Wyeth issues warning about venlafaxine use in children -
Oxcarbazepine (Trileptal) approved as monotherapy in children with epilepsy
The U.S. Food and Drug Administration has approved the first antiepileptic drug for monotherapy in children since 1978. -
Pharmacology Watch: Vardenafil Will Compete for Share of ED Market
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country. -
Clinical Briefs in Primary Care Supplement
-
Full October 2003 Issue in PDF
-
Seasonale: A Revolutionary Contraceptive